Rabeprazole is equivalent to omeprazole in the treatment of erosive gastro-oesophageal reflux disease: A randomised, double-blind, comparative study of rabeprazole and omeprazole 20mg in acute treatment of reflux oesophagitis, followed by a maintenance open-label, low-dose therapy with rabeprazole
- 31 October 2005
- journal article
- research article
- Published by Elsevier in Digestive and Liver Disease
- Vol. 37 (10), 741-750
- https://doi.org/10.1016/j.dld.2005.04.026
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Quality of life assessment in gastro-oesophageal reflux diseaseGut, 2004
- The impact of gastroesophageal reflux disease on quality of lifeSurgical Endoscopy, 2003
- Rabeprazole for the prevention of recurrent erosive or ulcerative gastro-oesophageal reflux diseaseEuropean Journal of Gastroenterology & Hepatology, 2000
- Rabeprazole, 20 mg Once Daily or 10 mg Twice Daily, Is Equivalent to Omeprazole, 20 mg Once Daily, in the Healing of Erosive Gastrooesophageal Reflux DiseaseScandinavian Journal of Gastroenterology, 2000
- A placebo‐controlled trial to assess the effects of 8 days of dosing with rabeprazole versus omeprazole on 24‐h intragastric acidity and plasma gastrin concentrations in young healthy male subjectsAlimentary Pharmacology & Therapeutics, 1998
- Gastro-oesophageal reflux disease in primary careEuropean Journal of Gastroenterology & Hepatology, 1998
- Relevance of Norm Values as Part of the Documentation of Quality of Life Instruments for Use in Upper Gastrointestinal DiseaseScandinavian Journal of Gastroenterology, 1996
- The relationship between the control of pH and healing and symptom relief in gastro‐oesophageal reflux diseaseAlimentary Pharmacology & Therapeutics, 1995
- Role of gastric acid suppression in the treatment of gastro-oesophageal reflux disease.Gut, 1992
- Symptomatic gastroesophageal reflux: Incidence and precipitating factorsDigestive Diseases and Sciences, 1976